{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.1444.3.175",
  "meta": {
    "versionId": "6",
    "lastUpdated": "2021-03-19T01:00:22.000-04:00"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.175",
  "version": "20210319",
  "name": "Immunotherapy Administration",
  "status": "active",
  "date": "2021-03-19T01:00:22-04:00",
  "publisher": "American Society of Clinical Oncology Steward",
  "compose": {
    "include": [
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20220301",
        "concept": [
          {
            "code": "180223008",
            "display": "Intravenous immunotherapy (procedure)"
          },
          {
            "code": "180244008",
            "display": "Intramuscular immunotherapy (procedure)"
          },
          {
            "code": "180256009",
            "display": "Subcutaneous immunotherapy (procedure)"
          },
          {
            "code": "589631000119102",
            "display": "Intravenous radioimmunotherapy using monoclonal antibodies (procedure)"
          },
          {
            "code": "60827006",
            "display": "Lymphokine activated killer cell therapy (procedure)"
          },
          {
            "code": "64644003",
            "display": "Immunotherapy for cancer (procedure)"
          },
          {
            "code": "72255009",
            "display": "Interleukin-2 therapy (procedure)"
          },
          {
            "code": "76334006",
            "display": "Immunotherapy (procedure)"
          },
          {
            "code": "84501003",
            "display": "Cytokine therapy (procedure)"
          },
          {
            "code": "870387009",
            "display": "Immune checkpoint inhibitor therapy (procedure)"
          }
        ]
      }
    ]
  }
}